|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
537,854 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,021,652 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
785,387 |
|
|
Total
Value |
$64,960,502 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
851 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 14 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-12-26 |
4 |
OE |
$21.51 |
$64,530 |
D/D |
3,000 |
330,530 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-01-07 |
4 |
AS |
$84.46 |
$253,380 |
D/D |
(3,000) |
327,530 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-01-07 |
4 |
OE |
$21.51 |
$64,530 |
D/D |
3,000 |
330,530 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-08-15 |
4 |
AS |
$95.21 |
$285,630 |
D/D |
(3,000) |
328,324 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-04-28 |
4 |
A |
$6.92 |
$23,393 |
D/D |
3,381 |
21,881 |
|
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-01-19 |
4 |
AS |
$20.89 |
$73,115 |
D/D |
(3,500) |
50,440 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-11-02 |
4 |
S |
$25.64 |
$89,750 |
D/D |
(3,500) |
93,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-01-18 |
4 |
AS |
$26.58 |
$93,030 |
D/D |
(3,500) |
90,067 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-05-01 |
4 |
AS |
$114.98 |
$402,992 |
D/D |
(3,505) |
248,654 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-04-01 |
4 |
AS |
$120.53 |
$422,590 |
D/D |
(3,506) |
251,251 |
0 |
- |
|
NGSX |
Neurogesx Inc |
See General Remarks |
|
2007-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,822 |
13,821 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-03-04 |
4 |
OE |
$6.46 |
$25,840 |
D/D |
4,000 |
31,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-03-04 |
4 |
S |
$38.00 |
$152,000 |
D/D |
(4,000) |
7,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-12-08 |
4 |
S |
$17.00 |
$67,988 |
D/D |
(4,000) |
10,917 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-12-08 |
4 |
B |
$17.20 |
$68,792 |
D/D |
4,000 |
14,917 |
2.81 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2009-11-19 |
4 |
S |
$8.15 |
$32,802 |
D/D |
(4,000) |
15,621 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-11-03 |
4 |
OE |
$6.46 |
$25,840 |
D/D |
4,000 |
97,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-11-03 |
4 |
S |
$25.46 |
$101,824 |
D/D |
(4,000) |
93,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-08-02 |
4 |
OE |
$6.46 |
$25,840 |
D/D |
4,000 |
135,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-09-14 |
4 |
OE |
$9.86 |
$39,440 |
D/D |
4,000 |
181,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-09-14 |
4 |
S |
$37.91 |
$151,628 |
D/D |
(4,000) |
177,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-09-28 |
4 |
OE |
$9.86 |
$39,440 |
D/D |
4,000 |
181,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-09-28 |
4 |
AS |
$40.20 |
$160,804 |
D/D |
(4,000) |
177,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-10-31 |
4 |
AS |
$37.68 |
$151,856 |
D/D |
(4,000) |
174,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-11-14 |
4 |
S |
$48.50 |
$193,987 |
D/D |
(4,000) |
167,691 |
0 |
- |
|
851 Records found
|
|
Page 14 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|